Posts

Allarity Therapeutics Files Registration Statement for Proposed $100 Million SPAC IPO

on

GSK’s Ris-Rez cuts death risk by 54% in relapsed small-cell lung cancer trial

on

Novartis board faces investor scrutiny after M&A misfires and R&D setbacks

on

Major Novartis shareholder calls for board shake-up after trial setbacks

on

Major Novartis shareholder calls for board shake-up after trial setbacks

on

Novartis’s Triple Clinical Setback Hits Shares and Weighs on Pharma Peers

on

FDA delays decision on Exelixis colorectal-cancer drug to March 2027

on

Lonza and CordenPharma expand US and injectable manufacturing capacity

on

Yarrow raises $150M

on

Disc challenges in polycythemia vera, but Silence retains the lead

on

Major Novartis shareholder calls for board shake-up after trial setbacks

on

Disc Medicine reports promising early PV data

on

Major Novartis shareholder calls for board shake-up after trial setbacks

on